Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 250Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Pletaal/Pletal

PharmaCompass

01

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 93

2019 Revenue in Millions : 110

Growth (%) : -16

blank

02

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 84

2020 Revenue in Millions : 89

Growth (%) : 1

blank

03

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 82

2021 Revenue in Millions : 84

Growth (%) : -2

blank

04

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 65

2022 Revenue in Millions : 82

Growth (%) : -10

blank

05

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 216

2015 Revenue in Millions : 288

Growth (%) : -25

blank

06

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 201

2016 Revenue in Millions : 227

Growth (%) : -11

blank

07

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 128

2017 Revenue in Millions : 188

Growth (%) : -32%

blank

08

Brand Name : Pletaal/Pletal

Cilostazol

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pletaal/Pletal

arrow
2024 ACI Convention
Not Confirmed

Cilostazol

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 108

2018 Revenue in Millions : 132

Growth (%) : -18

blank